Health
NHS to use world’s most expensive drug to treat spinal muscular atrophy – The Guardian
Zolgensma, which costs £1.79m for one-off treatment, will be available in England this year for the first time
NHSZolgensma, which costs £1.79m for one-off treatment, will be available in England this year for the first time
The worlds most expensive drug, which treats babies and young children with a rare and often fatal degenerative disorder, will be available this year for the first time on the NHS in England.
Zolgensma, which costs £1.79m per dose, halts the progression of spinal muscular atrophy (SMA), which involves loss of movement, muscle weakness and paralysis, and is the leading genetic cause of…
-
Business20 hours ago1 Australian stock you’ll probably kick yourself for not owning a decade from now
-
General17 hours agoProtecting victims of explicit AI content online
-
Business19 hours agoIs this the best ASX ETF to diversify your portfolio with?
-
Noosa News12 hours agoPeregian Square revitalised | Noosa Today